Dosage of Early Rehabilitation of ICU Patients

NCT06960642 · tracked via the Priya Life Science Austria tracker

Sponsor

Medical University of Vienna

Phase

Observational

Started

2025-12-14

Last updated

2026-02-20

Condition(s) studied

Critical Care, Intensive CareCritical IllnessPhysiotherapyEarly AmbulationInterprofessional Team Collaboration

Study summary

Rehabilitation already begins in the intensive care unit (ICU) to maintain or restore the functional capacity of ICU patients and to counteract the long-term effects of intensive care treatment. Mobilisation is an important component.

The aim of this multinational observational study is to record and evaluate the different mobilisation practices for ICU patients worldwide. The investigators want to find out which forms of mobilisation in intensive care patients achieve the best results in terms of physical function, functional status and quality of life.

The goal is to recruit over 6,000 patients internationally. No interventions will be carried out, only routine clinical data will be documented and standardised and already established physical tests and questionnaires will be used.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adults (≥ 18 years old) within 48 hours of ICU admission * Expected to stay \> 24 hours in the ICU Exclusion Criteria: * Patients who receive end-of-life care at the time of screening * Patients whose treatment plans are still under discussion and/or not all team members are committed to full active treatment * Patients whose functional status is unlikely to be obtainable * Patients with language barriers

Primary outcome measure(s)

Physical function at ICU discharge — ICU discharge (up to Day 28)
Physical function measured with the Functional Status Score for the Intensive Care Unit (FSS-ICU). The total score ranges from 0 to 35, with higher scores indicating better physical function.

Trial sites (1)

Facility	City	Region	Status
Medical University of Vienna	Vienna	State of Vienna	Recruiting

More Medical University of Vienna trials in Austria

BeFlared Versus VBX for FEVAR Recruiting

Neoadjuvant PSMA-RLT in Oligometastatic PCa Recruiting

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma Recruiting

Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction Recruiting

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps Starting soon

Other trials for the same condition

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients Recruiting

Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06960642 on ClinicalTrials.gov ↗ ← All trials in Austria